The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Leveraging the DNA damage and transcriptional-regulatory roles of PARP-1 as a means to improve prostate cancer therapy.
Matthew Joseph Schiewer
No relevant relationships to disclose
Jamin Steffen
No relevant relationships to disclose
Renee Tholey
No relevant relationships to disclose
Jonathan Robert Brody
No relevant relationships to disclose
John Pascal
No relevant relationships to disclose
Jianqing Lin
No relevant relationships to disclose
Robert Den
No relevant relationships to disclose
Felix Yi-Chung Feng
No relevant relationships to disclose
Leonard G. Gomella
No relevant relationships to disclose
Adam Dicker
No relevant relationships to disclose
William Kevin Kelly
No relevant relationships to disclose
Karen E. Knudsen
No relevant relationships to disclose